Averin Capital Acquisition Corp. 8-K

What Happened

• Averin Capital Acquisition Corp. announced the closing of its initial public offering on February 20, 2026. The company sold 25,000,000 units at $10.00 per unit, generating $250,000,000 in gross proceeds. Each unit consists of one Class A ordinary share and one-sixth of one redeemable warrant (each full warrant exercisable for one share at $11.50).
• The underwriter (Deutsche Bank Securities Inc., as representative) has a 45-day option to buy up to 3,750,000 additional units to cover over-allotments. Simultaneously, the company completed a private placement of 200,000 units to its Sponsor at $10.00 per unit (exempt from registration under Section 4(a)(2)).
• The company entered into customary IPO-related agreements (underwriting agreement, warrant agreement, trust agreement, registration rights, sponsor purchase agreement, administrative services, indemnity agreements, etc.) in connection with the offering.

Key Details

• IPO size: 25,000,000 units at $10.00 each = $250,000,000 gross proceeds.
• Private placement: 200,000 units to Sponsor at $10.00; no underwriting discounts or commissions.
• Trust account: $250,000,000 (including $13,750,000 of underwriter’s deferred discount) placed with Continental Stock Transfer & Trust Company as trustee; interest may be used for taxes and wind-up costs only.
• Governance: Ulrik Schulze, Graeme Bell and Mary T. Szela were appointed to the board (Feb 19, 2026) with committee assignments; the company entered into indemnity agreements for directors and officers.

Why It Matters

• The proceeds are held in trust pending the company’s initial business combination, limiting access to funds except for permitted uses (taxes/wind-up expenses) and protecting public investors until a deal is completed. If no business combination is completed within 24 months of the IPO closing (i.e., by Feb 20, 2028, unless extended), public shareholders can seek redemption under the company’s charter.
• Board appointments and indemnity agreements put leadership and director protections in place as the company pursues a target company. The private placement to the Sponsor and the underwriting option are typical SPAC structures that affect potential sponsor ownership and dilution.